Corient Private Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $443M | Buy |
2,380,205
+90,160
| +4% | +$16.8M | 0.47% | 38 |
|
|
2025
Q1 | $480M | Sell |
2,290,045
-43,870
| -2% | -$9.19M | 0.78% | 21 |
|
|
2024
Q4 | $414M | Buy |
2,333,915
+56,369
| +2% | +$10M | 0.69% | 25 |
|
|
2024
Q3 | $450M | Sell |
2,277,546
-31,721
| -1% | -$6.26M | 0.7% | 27 |
|
|
2024
Q2 | $396M | Buy |
2,309,267
+194,691
| +9% | +$33.4M | 0.69% | 26 |
|
|
2024
Q1 | $385M | Sell |
2,114,576
-66,316
| -3% | -$12.1M | 0.69% | 31 |
|
|
2023
Q4 | $338M | Buy |
2,180,892
+151,900
| +7% | +$23.5M | 0.62% | 33 |
|
|
2023
Q3 | $302M | Sell |
2,028,992
-1,140
| -0.1% | -$170K | 0.7% | 28 |
|
|
2023
Q2 | $273M | Buy |
2,030,132
+423,005
| +26% | +$57M | 0.63% | 32 |
|
|
2023
Q1 | $256M | Buy |
1,607,127
+467,514
| +41% | +$74.5M | 0.69% | 31 |
|
|
2022
Q4 | $184M | Buy |
+1,139,613
| New | +$184M | 0.67% | 31 |
|